Advertisement

Topics

Novartis confirms commitment to malaria elimination, with $200 million investment

09:34 EDT 17 Apr 2018 | thePharmaLetter

Swiss pharma giant Novartis today confirmed its commitment to the elimination of malaria, pledging to…

Original Article: Novartis confirms commitment to malaria elimination, with $200 million investment

NEXT ARTICLE

More From BioPortfolio on "Novartis confirms commitment to malaria elimination, with $200 million investment"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Novartis
Novartis is the fourth largest pharmaceutical company in the world, based on annual sales, which are exceeded $36,000m in 2009. Founded in 1996, Novartis focuses of four main areas; pharmaceuticals, vaccines & diagnostics, generic medicines and biosi...

Tropical Medicine
Tropical Medicine is the study of diseases more commonly found in tropical regions than elsewhere. Examples of these diseases are malaria, yellow fever, Chagas disease, Dengue, Helminths, African trypanosomiasis, Leishmaniasis, Leprosy, Lymphatic filaria...